Abstract |
Genetic epilepsy and neurodegenerative diseases are two common neurological disorders that are conventionally viewed as being unrelated. A subset of patients with severe genetic epilepsies who have impaired development and often go on to die of their disease respond poorly to anticonvulsant drug therapy, suggesting a need for new therapeutic targets. Previously, we reported that multiple GABAA receptor epilepsy mutations result in protein misfolding and abnormal receptor trafficking. We have now developed a model of a severe human genetic epileptic encephalopathy, the Gabrg2(+/Q390X) knock-in mouse. We found that, in addition to impairing inhibitory neurotransmission, mutant GABAA receptor γ2(Q390X) subunits accumulated and aggregated intracellularly, activated caspase 3 and caused widespread, age-dependent neurodegeneration. These findings suggest that the fundamental protein metabolism and cellular consequences of the epilepsy-associated mutant γ2(Q390X) ion channel subunit are not fundamentally different from those associated with neurodegeneration. Our results have far-reaching relevance for the identification of conserved pathological cascades and mechanism-based therapies that are shared between genetic epilepsies and neurodegenerative diseases.
|
Authors | Jing-Qiong Kang, Wangzhen Shen, Chengwen Zhou, Dong Xu, Robert L Macdonald |
Journal | Nature neuroscience
(Nat Neurosci)
Vol. 18
Issue 7
Pg. 988-96
(Jul 2015)
ISSN: 1546-1726 [Electronic] United States |
PMID | 26005849
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- GABRG2 protein, human
- Gabrg2 protein, mouse
- Receptors, GABA-A
|
Topics |
- Adult
- Animals
- Disease Models, Animal
- Epilepsy
(genetics, metabolism, pathology, physiopathology)
- Female
- Humans
- Mice
- Mice, Inbred C57BL
- Mice, Transgenic
- Mutation
- Neurodegenerative Diseases
(genetics, metabolism, pathology, physiopathology)
- Receptors, GABA-A
(genetics, metabolism)
- Young Adult
|